tiprankstipranks
TipRanksTop Financial ExpertsInsidersVuong Trieu

Vuong Trieu Insider Profile

4 Followers
Vuong Trieu, Chairman & CEO, Director, Ten Percent Owner at Oncotelic Therapeutics, holds 117.54M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Jun 24, 2026 for an estimated value of $10.20K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Vuong Trieu

Vuong Trieu
Oncotelic Therapeutics (OTLC)
Chairman & CEO, Director, Ten Percent Owner

Ranked #9,856 out of 108,575 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

+15.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$4M
100.00%
0.00%
A breakdown of Vuong Trieu's holdings
See the Top Stocks by Insiders

Insider Roles

Oncotelic Therapeutics
(OTLC)
Chairman & CEO, Director, Ten Percent Owner
Sorrento Therapeutics
(SRNE)
CSO, Director
Roles that Vuong Trieu holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Oncotelic Therapeutics
(OTLC)
Rating:Informative Buy
Date:Nov 26, 2024 - Nov 26, 2025
Return:+212.90%
The most profitable trade made by Vuong Trieu
See the Latest Stocks Traded by Insiders

Vuong Trieu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OTLC
Oncotelic Therapeutics
Jun 24, 2026
Chairman & CEO, Director, Ten Percent Owner
Informative Buy
10.20K
$4.47M
SRNE
Sorrento Therapeutics
Sep 19, 2013
CSO, Director
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Vuong Trieu's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Vuong Trieu insider profile FAQ

What is the percentage of profitable transactions made by Vuong Trieu?
The percentage of profitable transactions made by Vuong Trieu is 53%.
    What is the average return per transaction made by Vuong Trieu?
    The average return per transaction made by Vuong Trieu is 15.80%.
      What stocks does Vuong Trieu hold?
      Vuong Trieu holds: OTLC, SRNE stocks.
        What was Vuong Trieu’s latest transaction?
        Vuong Trieu latest transaction was an Informative Buy of $10.20K.
          What was Vuong Trieu's most profitable transaction?
          Vuong Trieu’s most profitable transaction was an Informative Buy of OTLC stock on November 26, 2024. The return on the trade was 212.90%.
            What is Vuong Trieu's role in Oncotelic Therapeutics?
            Vuong Trieu's role in Oncotelic Therapeutics is Chairman & CEO, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.